This document provides information on various topics related to alcoholism and its effects on the brain and body. It discusses:
1) The phenomenology of alcoholism including definitions of terms like alcoholic, alcohol dependence, binge drinking, craving, and tolerance.
2) How alcohol is metabolized and its effects on neurotransmitters in the brain. Chronic alcohol exposure can affect many genes and neurological systems.
3) The acute and chronic effects of alcoholism including intoxication, withdrawal, blackouts, seizures, nutritional deficiencies like Wernicke-Korsakoff syndrome, cerebellar degeneration, and other neurological complications.
4) Evaluation, diagnosis and treatment approaches for various alcohol-related
It may contain a brief intoduction of disease, etiology, types of parkinson disease, clinical findings, dignosis, pathophysiology, treatment, drug classification and their mechanisms of actions.
The structure of the human brain is extremely complex. It is made up of billions of neurons that are linked together by trillions of connections. Each part of the brain performs a certain set of functions. Damage to a specific area of the brain causes distinct clinical symptoms. Knowledge of neuroanatomy, functioning of different sections of the brain, and clinical manifestations caused by injury to a part of the brain are critical in locating a neurological lesion. The complexity of this knowledge frequently presents a problem to health practitioners. This activity emphasizes the significance of the physical examination in the localization of a neurological lesion. It is intended to provide a concise and easy-to-review summary of the subject.
SGLT2I The paradigm change in diabetes managementPraveen Nagula
Just like ARNI, SGLT2I have changed the face of diabetes management and they have a good profile in multimodality management because of pleiotropic effects
It may contain a brief intoduction of disease, etiology, types of parkinson disease, clinical findings, dignosis, pathophysiology, treatment, drug classification and their mechanisms of actions.
The structure of the human brain is extremely complex. It is made up of billions of neurons that are linked together by trillions of connections. Each part of the brain performs a certain set of functions. Damage to a specific area of the brain causes distinct clinical symptoms. Knowledge of neuroanatomy, functioning of different sections of the brain, and clinical manifestations caused by injury to a part of the brain are critical in locating a neurological lesion. The complexity of this knowledge frequently presents a problem to health practitioners. This activity emphasizes the significance of the physical examination in the localization of a neurological lesion. It is intended to provide a concise and easy-to-review summary of the subject.
SGLT2I The paradigm change in diabetes managementPraveen Nagula
Just like ARNI, SGLT2I have changed the face of diabetes management and they have a good profile in multimodality management because of pleiotropic effects
LPT05 - Treatment of Wernicke-Korsakoff Syndrome (Aug 2005)Alex J Mitchell
This is an academic presentation first given in 2005 to discuss the treatments available for Wernicke-Korsakoff Syndrome (alcohol related cognitive impairment)
The Mechanisms of Behavior Change project is studying how individuals are able to use self-control processes to reduce or quit drinking using brain imaging. The results may help us better understand the process of recovery and its relationship to addiction as a brain disease.
TEDx Manchester: AI & The Future of WorkVolker Hirsch
TEDx Manchester talk on artificial intelligence (AI) and how the ascent of AI and robotics impacts our future work environments.
The video of the talk is now also available here: https://youtu.be/dRw4d2Si8LA
Xenobiotics induced convulsions are constituting 15 percentage of ED seizures. EP should know in and outs of the DTS. This presentation explores various aspects of DTS in the ED
Derived from Greek word “enkephalos”- meaning brain.
“Pathos” meaning is disease.
The term “encephalopathy” is defined as altered mental status as a result of a diffuse disturbance of brain function.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
3. PHENOMENOLOGY
• Alcoholic = Person (T1>25yr M/F, T2<25yr male only)
• Alcoholism =Illness (abuse /dependence)
• Physical Dependence :The development of withdrawal
symptoms once a drug is stopped.
• Binge Drinking: A “binge” is a pattern of drinking alcohol
that brings BAC to 0.08 gm% or above. >5 drinks (male)
or >4 drinks (female) in about 2 hours.
• Craving:- The desire to experience the effects of a
previously experienced psycho-active substance.
• Tolerance:- represents a CNS pharmacodynamic adaptive
response which improves neurologic function at a given
blood alcohol level.
4. METABOLISM
• Role of alcoholism in the development of cognitive and
functional decline has been known since the time of
Hippocrates
• Two-carbon molecule that rapidly diffuses into virtually every
biologic compartment in the body upon ingestion.
• Women have a lower alcohol dehydrogenase blood content
than Men.
Rate of oxidation is
constant(15mg/dl/hr) does
not depend on plasma level.
6. ALCOHOL AND THE BRAIN TRANSCRIPTOME
• Chronic exposure acts by many multiple myelin-
related genes /ligand-gated ion channels /
neuromodulatory molecules /Neuroinflammatory
signaling genes are in both humans and animal
models (Blednov et al., 2011, 2012).
• Genetic predisposition - 50% of the vulnerability
for developing alcohol dependence (Goodwin et
al., 1974; Prescott and Kendler, 1999).
• Polymorphisms in isoforms of ADH and ALD genes,
which influence alcohol metabolism and the risk
for alcoholism (Park et al., 2013).
9. ACUTE EFFECTS- INTOXICATION
• Intoxication occurs –d/t readily crosses the BBB
• Facilitation of GABA and Inhibition of Glutmate
• Clinical intoxication is related to the rate of blood
ethanol increase and the individual’s ethanol
tolerance (d/t Zero order kinetics).
10. INTOXICATION
• EEG :- beta (fast) activity ----> slowing.
• Reduces sleep onset latency , sleep efficiency ,
duration of REM sleep and with diminished
perceived sleep quality.
Rx:-Supportive.
• Low dose BZD: Lorazepam PO/IV 1-2mg
• Alternative: Antipsychotic Haloperidol or
Olanzenpine.
• Parenteral thiamine should also used
11. ALCOHOL BLACKOUTS
• Alcohol blackouts occur in the absence of any
loss of consciousness or seizure activity and
represent a type of anterograde amnesia.
• Fragmentary or en bloc alcohol blackouts .
• Perhaps by interfering with septohippocampal
regulation of hippocampal neuronal circuitry
(Givens et al., 2000).
12. ALCOHOL WITHDRAWAL SYNDROME
Withdrawal
A physiological state, d/t cessation/reduction in
amount of drug ,Generally opposite of drug’s
normal effects.
Spectrum AWS
• Minor withdrawal= Tremulousness, 6-24 hrs
• Major withdrawal= Hallucinosis 10-72 hours
• Withdrawal seizures=Rum fit ,within 6-48 hrs
• Delirium tremens (DTs):-3-10 days
13. ALCOHOLIC HALLUCINOSIS
Alcoholic hallucinosis:
– Occurs in about 2% of patients
– Characterized by presence of hallucinations
[usually auditory] during partial or complete
abstinence, following regular alcohol intake.
Treatment:
– Lorazepam oral 3-10 mg every 4-6 hr
– Correction of electrolyte disorders: hypokalemia
and hypomagnesemia, hyperthermia,
14. ALCOHOLIC SEIZURE (RUM FITS)
– GTCS & multiple seizures occur in about 10% of
alcohol dependence patients, usually 12 to 48 hrs
after abstinence.
– Sometimes status epileptics can be precipitated
(less than 3%)
– Unless an underlying neuropathology exists,
seizures are rarely focal.
– Seizures sometimes occur during heavy drinking or
after more than a week without alcohol
– Arrhythmias and sudden cardiac death can occur.
– EEG are mildly abnormal and usually revert to
normal within few days
15. EFNS- RECOMMENDATION(2011)
Treatment: BDZ: Diazepam: IV 0.5 mg/kg at 2.5 mg/ min
No WS/Mild to Moderate symptoms no routine seizure prevention(Level B ).
Severe alcohol withdrawal symptoms, regardless of seizure occurrence, should
be treated pharmacologically (Level C recommendation).
Status epilepticus: i.v. lorazepam is safe and efficacious. When unavailable, i.v.
diazepam is a good alternative (Level A recommendation).
Primary Preventions
BZD for primary prevention of seizures in a person with alcohol withdrawal,
as well as for treatment of the alcohol withdrawal syndrome. Other drugs for
detoxification should only be considered as add -on (Level A).
Secondary prevention
BZD should be used for the secondary prevention of AWS (Level A).
Phenytoin is not recommended for prevention of AWS recurrence (Level A
recommendation).
The efficacy of other antiepileptics for secondary prevention of AWS is
undocumented.
16. DELIRIUM TREMENS
Occurs within 3 to 4 days
Features of:-
- Clouding of consciousness with disorientation
in time and place with tremulousness of body
- Poor attention span and distractibility
- Visual hallucinations and illusions
- Marked autonomic disturbances
- Insomnia
- Dehydration with electrolyte imbalance
Treatment: 50-100 mg Chlordiazepoxide every 4
hrs orally or Lorazepam IV 0.1 mg/kg at 2 mg/min.
Prevention: 25-50 mg of Chlordiazepoxide every 2-4 hrs until out of
danger.
High calorie, high carbohydrate diet given with Thiamine
suppliment.
17. CHRONIC COMPLICATIONS
Alcoholic Pellagra
• Disease of cerebral function attributed to
deficiency of nicotinic acid or tryptophan (Serdaru et al
1988; Victor 1994).
• Rare now because of widespread practice of
niacin supplementation of cereals and bread
• Initial symptoms are mood changes and
neurasthenia.May progress to lethargy and
confusion, variably accompanied by spastic
paresis, paratonia, or myoclonus.
18. Wernicke-Korsakoff Syndrome
German neurologist and
psychiatrist, born May 15, 1848,
Tarnowskie Gory, Poland; died
June 15, 1905,
Russian neuropsychiatrist,
born January 22, 1853,
Gus estate, Vladimirsk; died
May 1, Moscow, 1900.
Karl Wernicke(1848-1905)
19. WERNICKE ENCEPHALOPATHY
• WE is an acute, potentially reversible,
neuropsychiatric disorder caused by thiamine
deficiency (Donnino et al., 2007; Isenberg-Grzeda et al., 2012).
• The incidence can be as high as 12.5%
• The altered cognition of WE can progress to
KS, a chronic and usually permanent.(Toth et al., 2002).
• Approximately 80% of patients with acute WE
will develop KS (Donnino et al., 2007).
• Mechanism:- Chronic alcoholism– Malnutrition –
reduced thiamine uptake and utilization
20. PHYSICAL EXAMINATION
• The diagnosis of Wernicke syndrome is often suspected
based on clinical grounds.
• Theclassicaltriadofsymptoms–only1/3rd ofcases
• Ocularabnormalities–nystagmus,bilaterallateral
rectuspalsies,conjugategazepalsies,sluggishpupils,
ptosis,andanisocoria
• Encephalopathy– globalconfusionalstate,disinterest,
inattentiveness,or agitation;Comaisrare.
• Gaitataxia– cerebellardamage,andvestibularparesis
• Peripheralneuropathy– foot drop,anddecreased
proprioception
20
21. Figure 1. [A and B] FLAIR images depicting hyperintensities in the periaqueductal
region [A] and medial thalamus [B]. Pre- [C] and Post- [D] contrast T1-weighted images
showing contrast enhancement of the mammillary bodies.
Wernicke-Korsakoff Syndrome
23. WORK-UP
• Erythrocyte transketolase activity assay,
Thiamine assay – very specific tests – not
widely available – reserved for diagnostic
dilemmas
• EEG and CSF analysis may exclude other
explanatory or concomitant conditions.
24. TREATMENT
• Emergencydepartmentcare–Parenteralthiamine–Requirementin
chronicalcoholicsmaybeas highas500mgsingledoseormultipledaily
doses.
• NeverstartonDextrose
• Treatment with thiamine repletion, currently recommended at 1 gram of
IV thiamine per 24 hours for alcoholics with suspected Wernicke
encephalopathy , should not be delayed.
• Death occurs in nearly 20 % of patients with delayed treatment.
• Parenteralmagnesiumsulfateasthiaminetherapyineffectivein
presenceofhypomagnesemia.
• In-Patientcare–Watchforcomplications–Korsakoffpsychosis–Alcohol
withdrawal–Congestiveheartfailure–Lacticacidosis
• Out-PatientCare–Thiamine100mgPOdaily,startalcoholcessation
program,Adviseonimportanceofbalanceddiet.
24
25. KORSAKOFF SYNDROME:-
• Another CNS syndrome resulting from thiamine
deficiency in alcoholics.
• It manifests with Psychosis, memory loss and confabulation,
abulia.
• Korsakoff syndrome is distinguished from acute
Wernicke syndrome by prominent anterograde and
retrograde amnesia without substantially impaired
alertness and attention or extraocular movement
disturbance.
• 85% of the survivors of the acute phase of Wernicke
encephalopathy who remain untreated go on to develop
Wernicke-Korsakoffsyndrome.
• 20% eventuallyrecovercompletelyduring long-termF/U care.
26. KORSAKOFF SYNDROME
• Epidemiologicallly cases of undiagnosed Wernicke
syndrome can progress to Korsakoff syndrome.
• Patients may have a significant degree of
vacuous spontaneous speech and abulia that
may be mistaken for depressive symptoms when
inadequately explored.
• Thalamus (particularly the anterior thalamic
nucleus) and hypothalamus (medial mammillary
nucleus) are injured , but other cortical and
subcortical areas modulate this process.
27. PROGNOSIS OF WKS
• 10-20% mortality rate (in acute stages)
• In general, full recovery of ocular function occurs. Fine
horizontal nystagmus can persist in - 60% of cases.
• Approximately 40% of patients have complete recovery
from ataxia.
• Of patients surviving WE 80% have Korsakoff psychosis.
• KS 25% do not recover, require long-term admission.
• Only about 20% eventually recover completely during
long-term follow-up care.
• Only 20% of patients recover completely from amnestic
deficit.
• Despite appropriate treatment ,measureable memory
deficiency may persist for upto 2 years in patients with
Wernicke encephalopathy.
28. ALCOHOL RELATED DEMENTIA
• Represent approximately 10% of all cases of dementia
(Gupta and Warner, 2008).
• With advancing age , patients who are chronic
alcoholics may develop cognitive impairment or
dementia without demonstrable micronutrient
deficiency.
• Synergistic in the expression of other cognitive
disorders of aging.
• Clinically, patients with alcohol related dementia
typically present at an earlier age than other acquired
or late-onset forms of dementia.
29. ALCOHOL RELATED DEMENTIA
Pathogenesis
• Withdrawal-induced glutamate excitotoxicity
(Hoffman, 1995) or oxidative stress (Brust, 2010).
• Alter expression of numerous brain gene expression
networks
• Alcohol metabolite acetaldehyde binds to select
proteins, resulting in the formation of adducts. These
adducts led to brain damage (Nakamura et al., 2000).
• Neurotoxic glutamatergic excitation that leads to
hippocampal and neocortical neuronal loss.
30. ALCOHOL RELATED DEMENTIA
• AD may have symptoms that overlap with other
common neurodegenerative cognitive disorders(e.g)
• Contrast to the other dementia AD more typically
have a rather globally impaired neuropsychological
profile , with similar impairment in most or all
domains even in early disease stages.
• The evaluation :-Likewise other dementia
• Rx:- Partially reversible on cessation of drinking.
Gazdzinski et al. (2005)
31. MARCHIAFAVA BIGNAMI DISEASE
“red wine drinker’s encephalopathy,”
• Acute:- severe impairment of consciousness, seizures, and
muscle rigidity often result in death after several days.
• Chronic :-An interhemispheric disconnection syndrome,
such as limb apraxia, tactile agraphia, unilateral agraphia,
hemialexia, and dementia, can be seen and can last for
months to years (Kim et al., 2007).
• Corpus callosum demyelination is the hallmark of MBD
diseaseParticular involvement of the splenium.(Tozakidou et al., 2011)
• Rx:-Strongly associated with thiamine deficiency (and
recovery may therefore occur with early recognition and
repletion)
• Other clinical conditions such as ischemia, multiple
sclerosis, lupus, and posterior reversible encephalopathy
syndrome.
33. CEREBELLAR DEGENERATION
• CD with or without micronutrient deficiency
states , such as thiamine deficiency. Depends
on duration and severity of alcohol intake
(Nicolas et al., 2000)
• Typically occurs after 10 or more years of
alcohol abuse (Baker et al., 1999; Andersen,
2004).
• Thought to be the most common CNS
complication of alcoholism, affecting 10% to
25% of alcoholics.
34. CEREBELLAR DEGENERATION
• Most typically, the superior cerebellar vermis is
principally involved, with multilayer neuronal loss
(particularly affecting Purkinje cells) and cerebellar
white matter loss.
• The number of years of heavy alcohol abuse may be
the strongest single determinant of alcoholic ataxia
development.
• Treatment of this disorder , aside from thiamine and
other micronutrient repletion , is largely supportive
once developed.
• Cerebellar dysfunction may improves or stabilizes
with abstinence and improved nutrition (Diener et al., 1984).
35. CENTRAL PONTINE MYELINOLYSIS
• Possibility that alcoholics are predisposed to myelin
disorders by environmental insults such as
hyponatremia with CPM.
• CPM is C/b a loss of oligodendrocytes and myelin in the
central pons (Adams et al., 1959).
• EPM has also been described most often involving the
white matter of the cerebellum, lateral geniculate
body, putamen, thalamus, hippocampus, and cerebral
transition of white and gray matter (Martin, 2004).
• C/F confusion, impaired cognition, dysarthria,
dysphasia, gait instability, weakness or paralysis, and
generalized seizures (Hurley et al., 2011).
• Rx :-Correction of Na & Vitamin supplementation.
36. ALCOHOLIC NEUROPATHY
ACUTE ALCOHOLIC NEUROPATHY:-
• Rare cases have been reported of alcoholics with severe
acute or subacute neuropathy that mimics Guillain Barre´
syndrome.(causal but unproven)
• Biopsy and electrodiagnostic data show an axonal pattern
(not demyelinating) with normal CSF protein.
COMPRESSIVE NEUROPATHIES
• Susceptibility to compression is a feature of most axonal
neuropathies , and acute radial neuropathy , or Saturday
night palsy, in alcoholics is well reported.
• However , alcoholics with a generalized peripheral
neuropathy are prone to compression neuropathy at many
different sites , including ulnar neuropathy at the elbow ,
radial or axillary nerve injury in the axilla ( crutch-type
compression ) , and fibular ( peroneal) neuropathy at the
fibular head .
37. ALCOHOLIC NEUROPATHY
CHRONIC ALCOHOLIC NEUROPATHY:-
• Painful sensory neuropathy in association with alcoholism was
recognized in the late 1700s.
• However , the question of the cause due to ethanol as a
putative direct nerve toxin or due to nutritional deficiency or
both, was debated until recently.
• Malnutrition and vitamin deficiency are common in chronic
alcoholics , and thiamine has been the primary focus of
investigation.
• Clear association between reduction of thiamine levels or
transketolase activity and alcoholic peripheral neuropathy has
not been conclusively established.
38. CHRONIC ALCOHOLIC NEUROPATHY
• Peripheral distal sensorimotor neuropathy with distal
axonopathy that is a common finding in alcoholic
patients (90%).
• Distal weakness and atrophy are usually late findings
following sensory disturbance and are less profound ,
with weakness that may be limited to toe extensors.
• Differences in thiamine levels or enzyme activity
between alcoholics with and without neuropathy
have not been consistently identified , even though
alcoholic neuropathy patients often do have reduced
levels of various vitamins.
39. CHRONIC ALCOHOLIC NEUROPATHY:-
• Chronic well fed alcoholics without vitamin
deficiency - slowly progressive sensory loss
affecting small-fiber-mediated functions, but
not ataxia or weakness from neuropathy.
• Primary non-alcoholic thiamine deficiency-
subacute weakness and sensory ataxia from
large-diameter > small-diameter fiber sensory
neuropathy.
• Autonomic symptoms are not uncommon
40. ALCOHOLIC NEUROPATHY-Rx
• Cessation from ethanol is paramount to
improvement .
• Despite apparently adequate nutrition,
multivitamin supplements and thiamine are
indicated for all alcoholic neuropathy patients.
• Long-term follow-up of reformed alcoholics
demonstrates that significant improvement of
alcoholic neuropathy is possible, although often
incomplete.
• Patients with mild to moderate neuropathy can
significantly improve ,but the improvement is
usually incomplete in those with severe findings.
41. ALCOHOLIC MYOPATHY
ACUTE
• Develops over hours to days
following a recent binge.
• Painful, Proximal, may regional or
even focal, swollen muscles ,
variable weakness,
• Usually with myoglobinuria and
markedly elevated CK that
normalizes within 1 to 2 weeks.
• Muscle destruction –
Fasting/drinking
• Attacks can be recurrent,
correlating with additional
episodes of heavy drinking.
• Recovery following cessation of
drinking and repletion of
electrolytes is usually rapid and
dramatic.
CHRONIC
• Develops in an indolent manner
over many months. Roughly 2% of
all adults.
• Painless , proximal weakness with
wasting (up to 30%)
• Myoglobinuria is absent, and
creatine kinase(CK) is normal,
reduced, or mildly elevated, unless
an acute myopathy is
superimposed.
• Muscle Bx- atrophy of type II fibers,
which contain a higher content of
glycolytic enzymes.
• Prolonged abstinence can improve
clinical weakness and is associated
with significant improvement
42. TAKE HOME MESSAGE
• Alcoholism can produces a diverse spectrum
of neurologic disease when abused.
• Alcohol interacts acutely predominantly with
GABA-A and NMDA receptors, but triggers
diverse signaling events within well-defined
neural pathways.
• Early recognition and despite apparently
adequate nutritional deficiency one should
supplements thiamine and multivitamin for all
alcoholic patients.
This is the senerio where we stand inside and outside the country with alcohol burden. This map was polated by Nimhan study
Alcoholics are obsessed with alcohol and cannot control how much they consume, even if it is causing serious problems at home, work, and financially
, also known as alcohol usedisorder (AUD) and alcohol dependence syndrome, is a broad term for any drinking ofalcohol that results in problems. It was previously divided into two types: alcoholabuse and alcohol dependence.
This drug is almost ubiquitous, widely enjoyed socially, but produces a diverse spectrum of neurologic disease when abused
This fact may account for women’s tendency to become more intoxicated than men after drinking the same amount of alcohol.
There has been robust demonstration that acute or chronic alcohol exposure can alter expression of the genome
The explosion of genomic information about alcohol and the brain that has been produced since the turn of the century is almost bewildering in magnitude and scope (Contet, 2012; Farris and Miles, 2012).
mu-opioid receptor gene show promise as a pharmacogenetic risk factor altering responses to naltrexone, a mu-opioid receptor antagonist t- treatment of alcoholism (Ray and Hutchison, 2007; Ramchandani et al., 2011).
Hypothetic scheme for the role of myelin in alcoholism and alcohol-related neurologic disorders. Basal myelin expression is pictured as affecting initial sensitivity to alcohol, such as with loss-of-righting reflex (LORR), and perhaps relatedly, alcohol consumption. Acute alcohol, however, also alters myelin gene expression, which may contribute to frontal-lobe dysfunction and the consequent development of abusive alcohol consumption. Chronic alcohol exposure produces prominent decreases in myelin gene expression and myelin structural abnormalities. These are envisioned as contributing to frontal-lobe dysfunction in alcoholism and alcoholic dementia. Additionally, alcohol-induced myelin pathology may contribute as a risk factor to other alcohol-related neurologic diseases, such as Wernicke–Korsakoff’s syndrome (WKS), Machiafava–Bignami disease (MBD), central pontine myelinolysis (CPM), and cerebellar degeneration (CD).
Minor withdrawal
Minor withdrawal (withdrawal tremulousness) occurs within 6-24 hours following the patient’s last drink and is characterized by tremor, anxiety, nausea, vomiting, and insomnia.
Major withdrawal (alcoholic hallucinosis)
Major withdrawal (hallucinations) occurs 10-72 hours after the last drink. The signs and symptoms include visual and auditory hallucinations, whole body tremor, vomiting, diaphoresis, and hypertension.
Withdrawal seizures
Withdrawal seizures (rum fits) occur within 6-48 hours of alcohol cessation; they are major motor seizures that take place during withdrawal in patients who normally have no seizures and have normal electroencephalograms (EEGs). These seizures are typically generalized and brief. In the absence of treatment, multiple seizures occur in 60% of patients, but the duration between the first and last seizure is usually less than 6 hours. Only 3% of patients go on to develop status epilepticus.
An alcohol withdrawal seizure is frequently the first sign of alcohol withdrawal, and no other signs of withdrawal may be present after the seizure abates. About 30-40% of patients with alcohol withdrawal seizures progress to DTs.
Alcohol withdrawal seizures usually occur only once or recur only once or twice, and they generally resolve spontaneously. If a patient has seizures that are not typical of alcohol withdrawal seizures (such as partial or focal seizures, prolonged seizures, or seizures with a prolonged postictal state) or has signs of significant head trauma, then the underlying cause of the seizure should be investigated. Alcohol-dependent patients have increased rates of idiopathic epilepsy, traumatic brain injury, stroke, and intracranial mass lesions. Moreover, seizures in alcohol-dependent patients may be caused by concomitant use of stimulant drugs, such as cocaine or amphetamines, or by withdrawal from sedative agents, such as benzodiazepines or barbiturates.
Delirium tremens
DTs is the most severe manifestation of alcohol withdrawal. It occurs 3-10 days following the last drink. Clinical manifestations include agitation, global confusion, disorientation, hallucinations, fever, hypertension, diaphoresis, and autonomic hyperactivity (tachycardia and hypertension). Profound global confusion is the hallmark of delirium tremens.
Withdrawal seizures do not represent "latent" epilepsy; therefore, treatment with anticonvulsants is not recommended
Additionally, KS has additional causes other than WE, including primary CNS lymphoma (Toth et al., 2002) and mammillothalamic tract infarction (Yoneoka et al., 2004).
Ocular motor signs are attributable to lesions in the brainstem affecting the abducens nuclei and eye movement centers in the pons and midbrain.
Ataxia is a manifestation of damage to the cerebellum, particularly the superior vermis and also the vestibular apparatus
Idea is to exclude alternate or coexisting medical conditions.
In one study by Gazdzinski et al. (2005), Abstinent for 1 month and the tissue volume continued to increase over the next 6–9 months of abstinence, but at a slower rate than the first month following initial abstinence.
Sandwich sign
Ethanol does appear to directly interfere with retrograde axonal transport in some animal models.
Differences in thiamine levels or enzyme activity between alcoholics with and without neuropathy have not been consistently identified , even though alcoholic neuropathy patients often do have reduced levels of various vitamins.
Chronic well fed alcoholics without vitamin deficiency primarily develop slowly progressive sensory loss affecting small-fiber-mediated functions, especially nociception ;pain and burning paresthesia are common in this group ,but not ataxia or weakness from neuropathy.
Primary non-alcoholic thiamine deficiency associated neuropathy , in contrast, more typically produces prominent subacute weakness and sensory ataxia from large-diameter more than small-diameter fiber sensory neuropathy.
Patients with both alcohol exposure and thiamine deficiency demonstrate a mixture of findings that lead to similar treatment paradigms addressing both states.
Typically begin with distal paresthesia in the feet and slowly progress proximally.
In most cases , the onset is typically slow and insidious and may begin to affect the hands once leg symptoms ascend well above ankle level, thus yielding the classic symmetric stocking-glove sensory pattern.
Ankle deep tendon reflexes are typically lost at a relatively early stage.